Back
Recursion Pharmaceuticals Vs. Scholar Rock Holding Industry Stock Comparison
Buy
53
RXRX
Recursion Pharmaceuticals
Last Price:
6.00
Seasonality Move:
6.36%
Buy
100
SRRK
Scholar Rock Holding
Last Price:
37.85
Seasonality Move:
10.12%
Buy
53
Recursion Pharmaceuticals (RXRX)
is a Buy
Is Recursion Pharmaceuticals a Buy, Sell or Hold?
- The current Recursion Pharmaceuticals [RXRX] share price is $6.00. The Score for RXRX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- RXRX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
100
Scholar Rock Holding (SRRK)
is a Buy
Is Scholar Rock Holding a Buy, Sell or Hold?
- The current Scholar Rock Holding [SRRK] share price is $37.72. The Score for SRRK is 100, which is 100% above its historic median score of 50, and infers lower risk than normal.
- SRRK is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
RXRX Stock Price Chart
What is Recursion Pharmaceuticals's stock price today?
-
The Recursion Pharmaceuticals share price today is $6.00
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RXRX is experiencing slight selling pressure.
SRRK Stock Price Chart
What is Scholar Rock Holding's stock price today?
-
The Scholar Rock Holding share price today is $37.72
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRRK is experiencing selling pressure, which indicates risk of future bearish movement.
RXRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.2 | Sell |
| Relative Strength Index (14 RSI): | 42.07 | Sell |
| Chaikin Money Flow: | -9669295 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.08 - 7.12) | Sell |
| Bollinger Bands (100): | (6.22 - 7.62) | Sell |
SRRK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.83 | Buy |
| Relative Strength Index (14 RSI): | 74.99 | Buy |
| Chaikin Money Flow: | -5009875 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.64 - 31.02) | Buy |
| Bollinger Bands (100): | (6.08 - 25.5) | Buy |
RXRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.12 | Sell |
| 20-day SMA: | 6.61 | Sell |
| 50-day SMA: | 6.6 | Sell |
| 200-day SMA: | 8.3 | Sell |
| 8-day EMA: | 6.15 | Sell |
| 20-day EMA: | 6.45 | Sell |
| 50-day EMA: | 6.65 | Sell |
| 200-day EMA: | 7.66 | Sell |
SRRK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.8 | Buy |
| 20-day SMA: | 28.71 | Buy |
| 50-day SMA: | 22.69 | Buy |
| 200-day SMA: | 14.55 | Buy |
| 8-day EMA: | 30.11 | Buy |
| 20-day EMA: | 28.43 | Buy |
| 50-day EMA: | 23.91 | Buy |
| 200-day EMA: | 15.95 | Buy |
Recursion Pharmaceuticals Earnings Growth & RXRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and a decrease next year of $0.11 per share.
Scholar Rock Holding Earnings Growth & SRRK Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.56 per share, and an increase next year of $0.25 per share.
Recursion Pharmaceuticals Technical Analysis
| Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Scholar Rock Holding Technical Analysis
| Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||